YOLFTbeta
BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc. Common Stock

BHST · NASDAQ · Consumer Defensive / Packaged Foods

1.51USD-0.13 (-7.67%)

Price History

Full chart

Market Stats

Previous Close1.63
Open1.64
Day Range1.45 – 1.64
52-Week Range1.42 – 12.80
Volume9.83K
Market Cap33.10M
P/E (TTM)0.00
Forward P/E153.85
EPS-0.51
Dividend Yield0.00%
Beta1.35
50-Day Avg2.02
200-Day Avg3.73

About

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEODr. Zaki Rakib Ph.D.
  • Employees89
  • Headquarters1140-625 Howe Street, Vancouver, BC, Canada, V6C 2T6, USA
  • Websitehttps://www.bioharvest.com

Leadership

  • Dr. Zaki Rakib Ph.D.Co-Founder, CEO, Executive Chairman & President · b. 1959
  • Dr. Yoheved Hagay Ph.D.Co-Founder & CTO · b. 1958
  • Ms. Bar DichterChief Financial Officer
  • Dr. Ilana Belzer Ph.D.Chief Operating Officer · b. 1960
  • Mr. David K. RyanVP of Investor Relations & Secretary · b. 1967
  • Jared TurnerChief Sales Officer
  • Dr. Malkit Azachi Ph.D.Vice President of Research & Development
  • Ms. Michal Abargel SapirVice President of Regulatory Affairs

Financials

Income Statement

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue------218.00K396.00K2.10M5.50M12.67M25.19M34.51M
Growth (%)-------+81.65%+430.81%+161.56%+130.48%+98.77%+37.00%
Cost of Revenue--501.86501.16--189.00K258.00K1.43M4.28M7.04M11.25M14.03M
Gross Profit---501-501--29.00K138.00K670.00K1.22M5.63M13.94M20.48M
Gross Margin------13.30%34.85%31.87%22.17%44.45%55.35%59.34%
Operating Expense--121.17K96.14K--2.34M6.30M9.16M11.83M15.60M20.93M26.05M
Operating Income---121.67K-96.64K-5.00K-4.36M-2.31M-6.17M-8.49M-10.61M-9.97M-6.99M-5.58M
Operating Margin-------1059.63%-1557.07%-403.95%-193.02%-78.65%-27.75%-16.16%
EBITDA--198.81K-126.94K-93.22K-159.63K--1.98M-5.77M-8.64M-9.13M-9.76M-9.72M-6.71M
EBITDA Margin-------908.72%-1458.08%-410.87%-165.97%-77.04%-38.61%-19.45%
Net Income---123.72K-103.41K-5.00K--5.31M-6.58M-9.83M-11.24M-12.56M-12.91M-11.13M
Net Income Margin-------2435.78%-1662.63%-467.51%-204.37%-99.15%-51.27%-32.27%
R&D------1.35M1.26M4.13M2.31M3.37M4.80M5.31M
R&D as % of Total Revenue------617.43%319.19%196.43%41.98%26.59%19.04%15.39%
Interest Expense406.171.93K2.15K6.77K3.95K780.00K2.25M535.89K805.00K1.40M1.96M1.93M2.72M
Interest Expense % of Total Revenue------1032.11%135.33%38.30%25.45%15.48%7.66%7.89%

Balance Sheet

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets53.41K69.46K72.94K61.61K301.75K4.18M2.02M5.30M10.21M9.39M15.00M25.00M47.66M
Total Liabilities7.78K52.12K56.86K121.17K27.70K1.42M28.99M7.60M7.35M15.32M29.86M23.67M22.22M
Total Equity45.63K17.33K38.71K-59.57K274.05K2.76M-30.53M-2.29M2.85M-5.93M-14.85M1.33M25.45M
Cash43.44K17.90K16.81K1.36K216.29K395.61K911.00K1.78M4.12M1.74M5.36M2.39M23.02M
Total Debt-13.77K25.36K80.94K8.11K-26.22M2.71M2.66M10.56M22.34M13.82M14.10M
Net Debt-43.44K-4.13K8.55K79.58K-208.18K-395.61K25.31M932.00K-1.46M8.82M16.98M11.43M-8.92M

Cash Flow

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---126.82K-74.60K-1.00K--2.38M-3.88M-6.79M-9.24M-8.52M-6.68M-7.23M
Investing Cash Flow---32.40K-19.55K---34.00K-173.00K-1.64M-1.26M-1.47M-3.03M-2.37M
Financing Cash Flow120.11K95.02K159.62K73.28K1.00K2.23M2.12M4.93M10.77M8.14M13.56M6.78M30.19M
Capital Expenditure00000034.00K173.00K1.64M1.26M1.47M2.83M2.35M
Free Cash Flow---126.82K-74.60K-1.00K--2.42M-4.05M-8.43M-10.50M-10.00M-9.52M-9.58M
FCF to OCF--100.00%100.00%100.00%-101.43%104.46%124.14%113.59%117.30%142.41%132.59%

Earnings

Report DateMar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 29, 2024Aug 29, 2024Nov 25, 2024Mar 31, 2025May 15, 2025Aug 11, 2025Nov 13, 2025Mar 31, 2026Apr 1, 2026Aug 11, 2026Nov 12, 2026
EPS Estimate------------------0.10-0.05-0.12-0.15-0.11-0.11-0.10-0.12-0.13-0.16
EPS Actual-0.09-0.13-0.15-0.26-0.560.14-0.25-0.14-0.16-0.18-0.30-0.22-0.06-0.21-0.13-0.53-0.48-0.04-0.16-0.17-0.13-0.24-0.14-0.10-0.11-0.17-
Surprise-----------------60.00%-220.00%-37.88%13.33%-118.18%-27.27%0.00%8.33%-30.77%-
Timing-----------------After-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hours-Pre-marketPre-market

Key Statistics & Ratios

Market Cap33.10M
Enterprise Value35.74M
Trailing P/E0.00
Forward P/E153.85
Price / Sales0.93
Price / Book1.70
EPS-0.51
Book Value0.872
Revenue (TTM)35.48M
Gross Profit (TTM)20.91M
EBITDA-5.80M
Profit Margin-31.21%
Operating Margin-28.37%
Return on Equity-142.50%
Return on Assets-11.02%
Shares Outstanding22.67M
Shares Float19.32M
Beta1.35
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
7.42%
Insiders
14.77%
Retail / Other
77.81%

Top Institutional Holders

  • Alyeska Investment Group, L.P.
    757.06K3.34%
  • Thompson, Siegel & Walmsley LLC
    364.01K1.61%
  • True North Advisors LLC
    187.32K0.83%
  • Evercore Wealth Management, LLC
    139.47K0.62%
  • Magnus Financial Group LLC
    90.00K0.40%
  • Silverberg Bernstein Capital Management LLC
    57.72K0.25%
  • King Luther Capital Management Corp
    40.00K0.18%
  • XTX Topco Ltd
    29.65K0.13%
  • TD Waterhouse Canada Inc
    23.83K0.11%
  • Citadel Advisors Llc
    20.65K0.09%
  • Susquehanna International Group, LLP
    16.39K0.07%
  • Jane Street Group LLC
    13.08K0.06%
  • Geode Capital Management, LLC
    11.81K0.05%
  • Vident Advisory, LLC
    11.58K0.05%
  • K.j. Harrison & Partners Inc
    10.00K0.04%
  • Morgan Stanley - Brokerage Accounts
    3.25K0.01%
  • Royal Bank of Canada
    3.01K0.01%
  • UBS Group AG
    6290.00%
  • Advisor Group Holdings, Inc.
    6280.00%

Top Fund Holders

  • Fidelity Nasdaq Composite Index
    10.56K0.05%